Plasma Oncostatin M (OSM) has been proposed as a biomarker of disease activity in ulcerative colitis (UC). We evaluated OSM’s relationship with clinical, endoscopic, and histological activity across two follow-up visits, compared with fecal calprotectin (FC). One hundred UC patients were assessed at Visit 1 (baseline) and Visit 2 (12 months) for clinical (partial Mayo score), endoscopic (Mayo Endoscopic Score), and histological (Nancy Histological Index) activity, alongside plasma OSM, FC, CRP, and fibrinogen; 30 healthy controls were included for comparison. Given the marked right-skewness of OSM and FC, associations were assessed using both Pearson and Spearman correlations, and logistic regression effect sizes are reported as odds ratios per doubling of biomarker concentration (log2 scale). OSM correlated significantly with all activity measures at both visits, most strongly with histological activity (r = 0.521–0.602), but weakly or not with CRP/fibrinogen. OSM was significantly elevated versus controls at both visits (p < 0.001) and declined significantly with treatment response (Δ = −89.06 vs. +0.50 in controls, p = 0.006). FC was the dominant predictor of clinical (AUC = 0.788) and endoscopic (AUC = 0.926) remission at Visit 2, with OSM contributing little independent value; however, for histological remission, both baseline OSM and ΔOSM were independent, complementary correlates (OR = 8.43 and 9.64 per doubling, respectively; p < 0.001 for both), yielding the strongest model overall (AUC = 0.949). OSM’s discriminative accuracy improved markedly from Visit 1 to Visit 2 for endoscopic (AUC 0.695 → 0.897) and histological (AUC 0.738 → 0.927) activity. Across two follow-up assessments, OSM consistently reflected UC activity, with its strongest and most independent signal for histological inflammation, both as a concurrent correlate and—more modestly—as a genuine prospective marker independent of baseline treatment exposure. OSM’s incremental value over FC was most apparent for histological status and for stringent (MES 0) endoscopic remission, but not for conventional clinical or endoscopic remission thresholds.
The kidney is an essential organ that has a crucial role in preserving homeostasis within the human body. Kidney cancer is considered a major clinical challenge owing to its resistance to traditional treatments such as chemotherapy, radiotherapy, and immunotherapy. Nanoparticles (NPs) gain great attention in cancer therapy due to their low toxicity, biocompatibility, and targeted drug delivery capability. This review focuses on the current role of green-synthesized NPs in renal cell carcinoma management and their applications in targeted drug delivery and cancer-specific targeting mechanisms with the demonstration of the environmentally friendly green synthesis approaches utilizing biological resources such as plant extracts and microorganisms, highlighting their advantages over conventional synthesis methods in terms of biocompatibility, sustainability, and reduced toxicity. Moreover, the therapeutic potential of nanomaterials is discussed, including magnetic NP-mediated thermal therapy, photothermal therapy, gene delivery systems, and RNA interference-based strategies. We underscore the challenges and limitations of NPs, including in vivo toxicity, biodistribution, clinical translation, large-scale production, batch-to-batch variability, long-term safety, scalability, repeatability, regulation, and reproducibility. There is growing potential to improve the treatment of kidney cancer. Hence, the promising prospects of nanotechnology in kidney cancer treatment provide a foundation for future research and clinical application. This comprehensive article highlights the significant contributions of nanomedicine to oncology and shows an optimistic perspective for more effective and precise treatment strategies for kidney cancer.
Environmental conditions have an impact on animals’ immune systems. Neutrophils, as key components of innate immunity, rapidly respond to bacterial stimuli through the activation of inflammatory and migratory pathways. This study evaluated the transcriptional and functional responses of neutrophils derived from dogs living under different housing environments following in vitro lipopolysaccharide (LPS) stimulation. Distinct transcriptional profiles were observed among groups in genes associated with leukocyte adhesion (CD11b), chemokine signaling (CXCR1, CXCR2, and CXCL8), and cytokines (TNF-α, IL-1β, and IL-6). Additional cytokine analyses confirmed neutrophil activation and revealed differences in the magnitude and duration of cytokine secretion between groups. These findings indicate that environmental background may be associated with differences in both transcriptional responsiveness and cytokine production in canine neutrophils. Dogs originating from different housing conditions exhibited distinct patterns of inflammatory activation. The combined assessment of gene expression and cytokine secretion provides valuable insight into innate immune adaptation and might represent a useful approach for monitoring immune status in dogs.
Black soldier fly larvae (BSFL; Hermetia illucens) oil and flaxseed oil provide contrasting fatty acid profiles and may serve as alternative lipid feed materials in ruminant nutrition. This study assessed low-α-linolenic/high-linoleic flaxseed oil, BSFL oil, and their blends using an in vitro rumen fermentation screening with pooled bovine rumen inoculum and a randomized prepartum feeding trial in 32 twin- or triplet-bearing Olkuska ewes. In vitro, the single oils and a 1:1 blend were evaluated at two inclusion levels; total VFA concentration was unchanged, whereas propionate proportion, the acetate-to-propionate ratio, methane, ammonia, and incubation-fluid fatty acid profiles showed treatment-dependent responses. In vivo, an unsupplemented control was compared with flaxseed oil, BSFL oil, and a 2:1 blend supplied at 30 g/day for 21 days before expected parturition. Colostrum fat concentration differed among treatments (p = 0.036); the 2:1 blend group had a higher value than the control group (11.29% vs. 8.26%; Dunnett-adjusted p < 0.05), while major fatty acid classes did not differ. Supplementation was also associated with differences in selected minor colostrum fatty acids and several serum metabolic variables. Colostrum yield was not measured; therefore, this finding reflects fat concentration rather than total colostrum fat output. Serum total antioxidant status (TAS) was unaffected, while a treatment-by-time interaction was observed for γ-glutamyl transferase. The tested plant- and insect-derived oils therefore modified ruminal lipid transformations and selected maternal and colostrum traits without a detectable change in TAS.
Brucella abortus is an intracellular pathogen that must withstand oxidative stress and other hostile conditions encountered within host cells. Here, we investigated the contribution of BAB2_0534, a gene encoding a putative multicopper oxidase, to bacterial adaptation and persistence. Deletion of BAB2_0534 impaired pigment production in the presence of the melanin precursors L-DOPA and homogentisic acid, supporting a role for BAB2_0534 in phenolic substrate oxidation and melanin-like pigment biosynthesis. The mutant also exhibited increased susceptibility to oxidative stress and reduced survival with macrophages, indicating that BAB2_0534 contribute to intracellular adaptation. In vivo, mice infected with the ΔBAB2_0534 mutant showed significantly reduced splenic bacterial burdens compared with animals infected with the wild-type or complemented strains, demonstrating impaired persistence during infection. Consistently, Fontana–Masson-positive pigment was detected in tissues from wild-type-infected animals but was markedly reduced following infection with the mutant. Collectively, these findings support a model in which BAB2_0534-associated multicopper oxidase activity and pigment production contribute to oxidative stress resistance and intracellular persistence of B. abortus. This study characterizes BAB2_0534 as a previously unrecognized component of the adaptive mechanisms underlying Brucella persistence.
